Table 5. Five-year prevalence costs in selected cancer sites, 2010.
| Colorectal (2010 £,000s) | Breast (2010 £,000s) | Prostate (2010 £,000s) | Lung (2010 £,000s) | |||||
|---|---|---|---|---|---|---|---|---|
| Age group | 18–64 | ⩾65 | 18–64 | ⩾65 | 18–64 | ⩾65 | 18–64 | ⩾65 |
| Initial | 78 520 | 172 014 | 164 877 | 88 838 | 28 213 | 62 187 | 34 037 | 60 367 |
| Continuum | 85 883 | 139 380 | 223 635 | 104 489 | 45 871 | 144 476 | 14 395 | 23 474 |
| Terminal | 52 146 | 147 293 | 38 173 | 55 531 | 9 579 | 83 827 | 76 685 | 183 253 |
| Total health-care costs (A) | 216 549 | 458 688 | 426 685 | 248 858 | 83 663 | 290 490 | 125 117 | 267 095 |
| Comparison group costs (B) | 21 351 | 129 439 | 55 994 | 114 716 | 27 777 | 186 052 | 11 414 | 73 599 |
| Net health-care costs (A–B) | 195 198 | 329 249 | 370 691 | 134 142 | 55 886 | 104 438 | 113 703 | 193 496 |